Prognostic factors of recovery with medication in patients with taste disorders

被引:2
|
作者
Nomura, Yasuyuki [1 ]
Toi, Teruo [1 ]
Ikeda, Minoru [2 ]
Ikeda, Atsuo [1 ]
Tanaka, Makoto [1 ]
Oshima, Takeshi [1 ]
机构
[1] Nihon Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Tokyo, Japan
[2] Ikeda ENT Clin, Tokyo, Japan
来源
PLOS ONE | 2020年 / 15卷 / 10期
关键词
DOUBLE-BLIND; ZINC-DEFICIENCY; HYPOGEUSIA; SMELL; POLAPREZINC; RECEPTOR; SULFATE; TRIAL; AGE;
D O I
10.1371/journal.pone.0237270
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives We aimed to elucidate the prognostic factors of the patients with taste disorders who were treated with popular and common medication in Japan. Materials and methods A retrospective study on the medical charts of a total of 255 patients with taste disorders who were treated primarily with oral medication including a zinc agent. Results The factors below were significantly linked with poor prognosis: 1) male gender, 2) taste disorders that began 3 months before starting treatment and 3) a severe taste disorder grade at the initial visit. Conclusions We have concluded that the prognosis for the patients with taste disorders who were treated by popular and standard medication therapy in Japan recently was significantly linked to gender, the period of 3 months before starting the treatment and the severity of the disorder at the time of diagnosis. In addition, we recognized some limitations we should resolve in further research including a method of measuring "umami" and so on.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    Schaub, Christina
    Tichy, Julia
    Schaefer, Niklas
    Franz, Kea
    Mack, Frederic
    Mittelbronn, Michel
    Kebir, Sied
    Thiepold, Anna-Luisa
    Waha, Andreas
    Filmann, Natalie
    Banat, Mohammed
    Fimmers, Rolf
    Steinbach, Joachim P.
    Herrlinger, Ulrich
    Rieger, Johannes
    Glas, Martin
    Baehr, Oliver
    JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (01) : 93 - 100
  • [42] Prognostic factors of thymectomy in patients with myasthenia gravis -: A cohort of 132 patients
    Téllez-Zenteno, JF
    Remes-Troche, JM
    García-Ramos, G
    Estañol, B
    Garduño-Espinoza, J
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 491 - 493
  • [43] Multivariate analysis of prognostic factors in patients with lung cancer
    Liu, Changjiang
    Ma, Minting
    Zhou, Xuetao
    Zhang, Zefeng
    Guo, Yang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Prognostic factors of thymectomy in patients with myasthenia gravis:: A cohort of 132 patients
    Téllez-Zenteno, JF
    Remes-Troche, JM
    García-Ramos, G
    Estañol, B
    Garduño-Espinoza, J
    EUROPEAN NEUROLOGY, 2001, 46 (04) : 171 - 177
  • [45] Drug-Induced Taste Disorders in Clinical Practice and Preclinical Safety Evaluation
    Wang, Tao
    Glendinning, John
    Grushka, Miriam
    Hummel, Thomas
    Mansfield, Keith
    TOXICOLOGICAL SCIENCES, 2017, 156 (02) : 315 - 324
  • [46] Differences in the Density of Fungiform Papillae and Composition of Saliva in Patients With Taste Disorders Compared to Healthy Controls
    Walliczek-Dworschak, Ute
    Schoeps, Franz
    Feron, Gilles
    Brignot, Helene
    Haehner, Antje
    Hummel, Thomas
    CHEMICAL SENSES, 2017, 42 (08) : 699 - 708
  • [47] Factors influencing the occurrence of electrolyte disorders in cancer patients
    Alem, Addis
    Edae, Chala Kenenisa
    Wabalo, Endriyas Kelta
    Tareke, Amare Abera
    Bedanie, Almaz Ayalew
    Reta, Wondu
    Bariso, Moyeta
    Bekele, Gadisa
    Zawdie, Belay
    SAGE OPEN MEDICINE, 2021, 9
  • [48] The implications of medication development in the treatment of substance use disorders in developing countries
    Thirthalli, Jagadisha
    Chand, Prabhat K.
    CURRENT OPINION IN PSYCHIATRY, 2009, 22 (03) : 274 - 280
  • [49] Antipsychotic Medication for Bipolar I Disorders
    Juckel, G.
    NERVENARZT, 2012, 83 (03): : 384 - +
  • [50] Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
    Stark, Andreas M.
    van de Bergh, Julia
    Hedderich, Juergen
    Mehdorn, H. Maximilian
    Nabavi, Arya
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (07) : 840 - 845